P M Sweetnam

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Medicine, Pharmacology, Pharmacotherapy +10

EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART)

M L Burr, James Gilbert, Ruth M. Holliday et al. · The Lancet · 1989 · 2.6K citations

Agriculture, Nutrition, Nutritional Sciences +14

Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.

J. W. G. Yarnell, Ian Baker, P M Sweetnam et al. · Circulation · 1991 · 924 citations · Full text

Medicine, Cardiology, Internal Medicine +13

A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction

P C Elwood, Alexandra Cochrane, M L Burr et al. · BMJ · 1974 · 519 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Birthweight, body-mass index in middle age, and incident coronary heart disease

Stephen Frankel, P C Elwood, George Davey Smith et al. · The Lancet · 1996 · 516 citations

Medicine, Cardiology, Maternal Health +15